A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
Clinical trial NCT01747915 · COMPLETED
Trial details
- NCT number
- NCT01747915
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-03
- Primary completion
- 2019-02-20
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.